GABAB receptor-mediated presynaptic inhibition of glycinergic transmission onto substantia gelatinosa neurons in the rat spinal cord
Abstract
The GABAB receptor-mediated presynaptic inhibition of glycinergic transmission was studied from young rat substantia gelatinosa (SG) neurons using a conventional whole-cell patch clamp technique. Action potential-dependent glycinergic inhibitory postsynaptic currents (IPSCs) were recorded from SG neurons in the presence of 3
mM kynurenic acid and 10
μM SR95531. In these conditions, baclofen (30
μM), a selective GABAB receptor agonist, greatly reduced the amplitude of glycinergic IPSCs and increased the paired-pulse ratio. Such effects were completely blocked by 3
μM CGP55845, a selective GABAB receptor antagonist, indicating that the activation of presynaptic GABAB receptors decreases glycinergic synaptic transmission. Glycinergic IPSCs were largely dependent on Ca2+ influxes passing through presynaptic N- and P/Q-type Ca2+ channels, and these channels contributed equally to the baclofen-induced inhibition of glycinergic IPSCs. However, the baclofen-induced inhibition of glycinergic IPSCs was not affected by either 100
μM SQ22536, an adenylyl cyclase inhibitor, or 1
mM Ba2+, a G-protein coupled inwardly rectifying K+ channel blocker. During the train stimulation (10 pulses at 20
Hz), which caused a marked synaptic depression of glycinergic IPSCs, baclofen at a 30
μM concentration completely blocked glycinergic synaptic depression, but at a 3
μM concentration it largely preserved glycinergic synaptic depression. Such GABAB receptor-mediated dynamic changes in short-term synaptic plasticity of glycinergic transmission onto SG neurons might contribute to the central processing of sensory signals.
Keywords: GABAB receptor, Substantia gelatinosa, Glycinergic IPSCs, Presynaptic inhibition, Pain
To access this article, please choose from the options below
PII: S0304-3959(08)00014-6
doi:10.1016/j.pain.2008.01.005
© 2008 International Association for the Study of Pain. Published by Elsevier Inc. All rights reserved.

